CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
16 Apr 2024: ADC Therapeutics Accelerates R&D with Genedata Biologics
- ADC Therapeutics has partnered with Genedata Biologics, a leading provider of enterprise software for biopharmaceutical R&D
- ADC Therapeutics utilizes Genedata Biologics to streamline the development of next-gen antibody-drug conjugates (ADCs) for cancer treatment
- The platform aids in building and advancing ADC Therapeutics’ pipeline for hematological malignancies and solid tumors
- ADC Therapeutics chooses Genedata Biologics for its ability to manage complex ADC development workflows and protect intellectual property
- Genedata Biologics integrates seamlessly with ADC Therapeutics’ laboratory instruments and IT infrastructure for data traceability and integrity
- ADC Therapeutics, a global leader in ADC technology, aims to transform cancer treatment paradigms with its proprietary ADCs, including ZYNLONTA
